Sypsa et al. highlight the efficacy of peer-driven programmes to early identify a localised HIV outbreak and to implement health responses to mitigate it.
Neale et al. highlight diversity of experiences and need to offer a broad range of interventions, including pharmacotherapy, psychosocial support and safe spaces.
HRI and PRI discuss challenges, practices and opportunities related to the inclusion and prioritisation of people who use drugs and people in prison in the design, planning, and rolling-out of COVID-19 vaccination programs.
This webinar will underscore the importance of facilitating access to COVID-19 vaccines by people who use drugs, without discrimination, including through harm reduction services.
Join the African Network of People who Use Drugs (AfricaNPUD), with speakers from UNAIDS and from the community, for the launch of a landmark report documenting this situation which can inform future drug laws and policies and enhance human rights advocacy among people who use drugs in Africa.
Allowing people to access their OAT medication through a local pharmacy would reduce the arbitrary and punitive logics that pervade the current system.
WHO Director-General offers an overview of recent developments, including in relation to the impact of the COVID-19 pandemic and access to controlled medicines, and calls for a public health approach.
This evaluation on the work of UNAIDS highlights the programme's importance in supporting key population responses and the need for prioritising in programming to address inequalities
PRI has developed the 10-point plan as a tool to provide practitioners and policy makers guidance on building and strengthening services that are flexible, non-discriminatory and better able to respond to and adapt in the face of crises.
On 20 January 2022, PRI will hold an online event to launch the new 10-point plan, discuss key findings from the conducted research and hear about the experience of non-custodial sanctions during the ongoing pandemic from varied perspectives.
This PITCH paper highlights examples of positive shifts in policy, programme and service delivery as well as rights protections for people living with and at greatest risk of HIV, in response to the COVID-19 pandemic.
